Sonoma Pharmaceuticals (NASDAQ:SNOA) Stock Crosses Above Two Hundred Day Moving Average of $0.33

Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA)’s share price crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $0.33 and traded as high as $4.48. Sonoma Pharmaceuticals shares last traded at $3.83, with a volume of 1,273,066 shares.

Sonoma Pharmaceuticals Stock Down 10.9 %

The firm has a fifty day moving average of $0.93 and a 200-day moving average of $0.33. The firm has a market cap of $72.79 million, a P/E ratio of -5.25 and a beta of 1.37.

Sonoma Pharmaceuticals (NASDAQ:SNOA) last issued its quarterly earnings data on Thursday, August 8th. The company reported $0.00 EPS for the quarter. Sonoma Pharmaceuticals had a negative return on equity of 65.66% and a negative net margin of 35.91%. The firm had revenue of $3.39 million for the quarter. On average, equities analysts forecast that Sonoma Pharmaceuticals, Inc. will post -4 EPS for the current year.

About Sonoma Pharmaceuticals

Sonoma Pharmaceuticals, Inc, develops and produces stabilized hypochlorous acid (HOCl) products for wound care, animal health care, eye care, oral care, and dermatological conditions in the United States, Latin America, Europe, Asia, and internationally. The company offers Regenacyn, a prescription scar gel; Pediacyn, a pediatric dermatology and wound care product for over-the-counter (OTC) use; Epicyn, an Antimicrobial Facial Cleanser; Levicyn, an HOCl based prescription and OTC product to use and relieve skin irritations, lacerations, abrasions, and burns; Celacyn, a scar management gel; and SebuDerm to manage and relieve the burning, itching, erythema, scaling, and pain associated with seborrhea and seborrheic dermatitis.